TrialBMC cancer2021

Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer.

Noriyuki Hirahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.